What Is IBS-M (Mixed IBS)?
IBS-M stands for Irritable Bowel Syndrome — Mixed type, characterised by alternating episodes of constipation and diarrhoea — often in the same week or even the same day. It is the most common IBS subtype and the most difficult to manage because the treatment approaches for constipation and diarrhoea directly conflict. This internal contradiction is why standard IBS medications consistently fail IBS-M patients.
Why IBS-M Is Harder to Treat
- Fibre supplements — help constipation episodes but trigger or worsen diarrhoea episodes in IBS-M
- Loperamide for diarrhoea — causes severe constipation rebound in IBS-M patients
- Laxatives for constipation — precipitate uncontrollable diarrhoea
- Antispasmodics — reduce cramping without addressing the alternating motility dysfunction
Effective IBS-M treatment requires identifying the root cause — most commonly SIBO, dysbiosis, or visceral hypersensitivity — and treating that specifically, rather than chasing alternating symptoms reactively.
Diet for IBS-M — Managing Both Ends
- Regular meal timing is the most important single change — fixed meal times regulate the gastrocolic reflex and reduce the erratic transit that drives alternating symptoms
- Low-FODMAP diet during flares — reduces fermentation that destabilises both transit directions
- Soluble fibre (psyllium) in very small, gradually increasing doses — can help regulate both symptoms when introduced carefully; avoid insoluble fibre (wheat bran)
- Avoid caffeine — a potent and unpredictable gut stimulant in IBS-M
Is IBS-M Curable?
When the underlying cause is identified and treated, IBS-M resolves rather than just being managed. The most impactful finding is SIBO — IBS-M that resolves completely after SIBO treatment is one of the most satisfying outcomes in gut medicine. Dysbiosis-driven IBS-M responds equally well to targeted microbiome restoration. The key is accurate diagnosis before treatment — not trial-and-error symptom management.
The AYUSH Approach to Mixed IBS
In Ayurveda, IBS-M is a combined Vata-Pitta disorder — irregular movement combined with inflammatory reactivity. Dual-action treatment: Bilwadi churna for diarrhoea episodes; Gandharva haritaki for constipation episodes; Kutaja for the underlying inflammatory component. Dietary stabilisation and microbiome restoration complete the protocol. At Thavira, IBS-M patients follow a 10–12 week programme with the root cause confirmed through testing before treatment begins.